Tag: US Food and Drug Administration

June 17, 2018

Cannabis Weekly Round-Up: The Amendment Fight for Bill-C45

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
June 1, 2018

Cannabis Weekly Round-Up: Lift Cannabis Expo Takes Charge

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 24, 2018

Medicenna Receives Amendment to Revamp Clinical Trial

The Investing News Network had the opportunity to speak with Medicenna CEO Fahar Merchant at the Bloom Burton & Co....
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 29, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 27, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 26, 2018

Axsome Therapeutics Announces Interim Analysis of STRIDE-1 Trial

Shares of Axsome increased nearly 20 percent after the announcement, but evened out to an overall 13.21-percent increase to $3.
April 24, 2018

Immunovaccine and Incyte Expand Collaboration

Collaborations are allow companies sharing scientific integrity to build their pipelines without giving away the rights to their products.